waned – Page 5 – Communicable Diseases Research

Safety and immunogenicity of inactivated COVID-19 vaccine in health care workers

의료 종사자에서 비활성화된 COVID-19 백신의 안전성 및 면역원성

Article

Published on 2022-04-012022-09-11
Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 진단, 치료법,

Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation

동종 조혈 세포 이식 후 환자에서 SARS-CoV-2 백신 접종에 대한 항체 반응

Article

Published on 2022-04-012022-09-11
Journal: Transplantation and cellular therapy [Category] COVID19(2023년), SARS, 치료법,

[키워드] age Allogeneic Allogeneic hematopoietic cell transplantation Analysis antibody antibody levels Antibody Response Antibody titer Antibody titers approved BNT162b2 Cell cell transplantation chronic GVHD Cohort conditioning regimen conducted Critical disease domain Efficacy examined Factor Graft-versus-host disease group GVHD had no healthy control healthy controls healthy volunteers hematopoietic Hematopoietic cell transplantation highest homogenous humoral immune response IgA IgG IgM immune response immune responses Immunocompromised patients Immunosuppression information intensity Moderna mRNA mRNA vaccine mRNA vaccines mRNA-1273 nucleocapsid protein pandemic Patient physician reactivity receiving Receptor-binding domain recipient recipients regimen response revaccination S1 and S2 SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 antigens SARS-CoV-2 pandemic SARS-CoV-2 vaccination second dose significantly lower single center spike glycoprotein stratified subunit Switzerland the SARS-CoV-2 the vaccine transplantation Treatment underlying disease vaccination Vaccine waned was performed
[DOI] 10.1016/j.jtct.2022.01.019 PMC 바로가기 [Article Type] Article

Vaccine-induced and naturally-acquired protection against Omicron and Delta symptomatic infection and severe COVID-19 outcomes, France, December 2021 to January 2022

오미크론 및 델타 증상 감염 및 심각한 COVID-19 결과에 대한 백신 유도 및 자연 획득 보호, 프랑스, 2021년 12월 ~ 2022년 1월

Article

Published on 2022-04-012022-09-11
Journal: Eurosurveillance [Category] COVID19(2023년), SARS, 변종,

Predicting the mutational drivers of future SARS-CoV-2 variants of concern

우려되는 미래 SARS-CoV-2 변이체의 돌연변이 동인 예측

Article

Published on 2022-02-232022-09-11
Journal: Science Translational Medicine [Category] COVID19(2023년), SARS, 변종,

[키워드] advance Affect Amino acid antibodies applied approach Behavior binding Causal structure contribute covariate driver Effect Efficacy elevated epidemiological Epidemiology Evidence Evolution feature genomic high accuracy host immunity immunology IMPROVE Influenza Mutation natural infection natural infection-derived immunity omicron pandemic pathogen Pathogens predict Predictive Predictive value protein sequence public health Receiver operator characteristic SARS-CoV-2 SARS-CoV-2 evolution SARS-CoV-2 variant shifting Spread surveillance data tested therapeutic therapeutic antibodies Transmissibility Vaccine variants of concern viral fitness viruses waned
[DOI] 10.1126/scitranslmed.abk3445 PMC 바로가기 [Article Type] Article

Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine

Immunology

Published on 2022-01-312022-11-01
Journal: Frontiers in Immunology [Category] COVID-19,

[키워드] acute respiratory syndrome age Analysis analyzed antibody antibody level Antibody titer blood sample BNT162b2 mRNA BNT162b2 mRNA vaccine body mass index booster vaccination Characteristics Comorbidity coronavirus coronavirus disease COVID-19 COVID-19 vaccination COVID-19 vaccine dose effective Effectiveness enrolled evaluate examined females first vaccination had no healthcare personnel healthcare worker interquartile range IQR Korea median Month NAb neutralizing antibody no evidence of objective participant performed positive prospective observational study Quantitative response Result SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 neutralizing antibody second second vaccination single center South Korea subject the antibody response university vaccination Vaccine waned were measured while worker
[DOI] 10.3389/fimmu.2022.827306 PMC 바로가기 [Article Type] Immunology

Immunogenicity of a Heterologous Prime-Boost COVID-19 Vaccination with mRNA and Inactivated Virus Vaccines Compared with Homologous Vaccination Strategy against SARS-CoV-2 Variants

Article

Published on 2022-01-032022-10-28
Journal: Vaccines [Category] COVID-19,

[키워드] 95% CI adverse event blood sample BNT162b2 collected comparable CoronaVac COVID-19 D614G declined Delta variants dose Effectiveness evaluated geometric mean titre GMT group groups heterologous vaccination heterologous vaccine homologous immunogenicity Live virus microneutralization mRNA naïve Neutralization antibody Neutralizing activity neutralizing antibody participant recruited reduced Safe SARS-CoV-2 SARS-CoV-2 variant severe adverse events Strategy the antibody response the mean the SARS-CoV-2 the vaccine Vaccination strategy Vaccine vaccine immunogenicity Vaccines variant variants virus waned wild-type
[DOI] 10.3390/vaccines10010072 PMC 바로가기 [Article Type] Article

Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting

Immunology

Published on 2021-12-222022-11-01
Journal: Frontiers in Immunology [Category] COVID-19, SARS,

[키워드] acute respiratory syndrome binding domain CD4+ CD4+ T cell CD8+ T cell cellular cellular immune responses characterization characterized clinical trials Concentration concerning conditions coronavirus coronavirus disease COVID-19 COVID-19 vaccine COVID-19 vaccines COVID‐19 cytokine demonstrated detectable dose dosing interval elicited Evidence Frequency humoral humoral immune response humoral immune responses IFN-γ IgG IgG response IL-2 immune response Immunity inactivated Inactivated vaccine individual individuals induced longitudinal analysis majority male membrane neutralizing antibody nucleocapsid parameter participant peptide pool Protein raised recognizing response S-RBD SARS-CoV-2 SARS‐CoV‐2 second dose second vaccination setting significantly higher single vaccine sustained the SARS-CoV-2 TNF-α vaccination Vaccine vaccinees waned while
[DOI] 10.3389/fimmu.2021.802858 PMC 바로가기 [Article Type] Immunology

Waning Immunity after the BNT162b2 Vaccine in Israel

이스라엘에서 BNT162b2 백신 후 면역 약화

Article

Published on 2021-12-092022-09-11
Journal: The New England Journal of Medicine [Category] MERS, SARS, 변종, 진단,

[키워드] (rate ratio 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age all age group all age groups B.1.617.2 BNT162b2 BNT162b2 vaccine calculated collected confounding factors coronavirus coronavirus disease Coronavirus disease 2019 database delta variant Effectiveness eligible Immunity Infection mass vaccination National Older outbreak Poisson regression model rate of infection rate ratio receipt reduced respiratory resurgence SARS-CoV-2 SARS-COV-2 infection second dose second dose of vaccine severe acute respiratory syndrome Coronavirus severe COVID-19 severe disease Stratification the vaccine used data vaccination Vaccine variant variant of SARS-CoV-2 waned waning immunity
[DOI] 10.1056/NEJMoa2114228 PMC 바로가기 [Article Type] Article

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar

카타르에서 SARS-CoV-2 감염에 대한 BNT162b2 백신 보호 약화

Article

Published on 2021-12-092022-09-11
Journal: The New England Journal of Medicine [Category] Fulltext, MERS, 변종,

Cross-Sectional Assessment of SARS-CoV-2 Viral Load by Symptom Status in Massachusetts Congregate Living Facilities

Article

Published on 2021-11-222022-11-15
Journal: The Journal of Infectious Diseases [Category] SARS, 진단,